CSF Author Interview: Professor Martin Bergman, 2023
Professor Peter Nash from the Griffith University in Brisbane, is joined by Professor Martin Bergman, a Clinical Associate Professor of Medicine at the Drexel University College of Medicine in Philade...
11 Okt 202327min
Upadacitinib treating bDMARD-IR PsA & Post-marketing surveillance of tofacitinib treating PsA & RA
Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Australia, is joined by Laura Coates, an Associate Professor...
11 Okt 202331min
AxSpA Podcast: The Efficacy and Safety of Ixekizumab & Tildrakizumab
Dr Sofia Ramiro, consultant rheumatologist and senior researcher at Zuyderland Medical Centre and Leiden University Medical Centre in the Netherlands, is joined by Professor Hideto Kameda, Professor o...
25 Sep 202325min
Discussing Rheumatology: September 2023
Join Prof Iain McInnes as he reviews two interesting papers , that retrospectively investigate the properties of JAK inhibitors. In our first paper, Peter Taylor and his colleagues review the pharma...
25 Sep 202311min
Author Interview: Sofia Ramiro
Professor Peter Nash from the Griffith University in Brisbane, is joined by Doctor Sofia Ramiro, a Consultant Rheumatologist and Senior Researcher at Leiden University Medical Centre to discuss her re...
31 Aug 202324min
Discussing Rheumatology: August 2023
Join Prof Iain McInnes as he reviews two interesting papers. Our first paper today by Charles-Schoeman and colleagues compared paraoxonase activity in RA patients treated with tofacitinib, with a f...
22 Aug 20238min
AxSpA Podcast: Tofacitinib, Golimumab, and Fatigue
Join Professor Hideto Kameda, and Dr Sofia Ramiro as they discuss the latest top research in axSpA. In this edition, our Steering Committee members discuss two of the latest papers in the field of axS...
16 Aug 202319min
Discussing Rheumatology: July 2023
Join Prof Iain McInnes as he reviews two interesting papers. Our first paper today by Roy Fleischmann and his colleagues compares the incidence of serious adverse events in RA patients with a highe...
19 Juli 202310min
